Rapport Therapeutics CEO Abraham Ceesay sells $143,272 in stock
AI Summary
Rapport Therapeutics CEO Abraham Ceesay sold company stock valued at $143,272. The report concerns an insider transaction in the biotechnology firm's shares.
Rapport Therapeutics CEO Abraham Ceesay sold company stock valued at $143,272. The report concerns an insider transaction in the biotechnology firm's shares.
Yahoo Sports —
Globo —
Channel NewsAsia —
Container News —
Simple Flying Aviation —
The Sydney Morning Herald —